Literature DB >> 23328744

Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth.

Chuanlai Shen1, Kai Cheng, Shenwei Miao, Wei Wang, Yong He, Fanyan Meng, Jianqiong Zhang.   

Abstract

Cell-free artificial antigen-presenting cells (aAPCs) were generated by coupling H-2K(b)/TRP2 tetramers together with anti-CD28 and anti-4-1BB antibodies onto cell-sized latex beads and injected intravenously and subcutaneously into naïve mice and antigen-primed mice (B6, H-2K(b)). Vigorous tumor antigen-specific CTL responses in the native T-cell repertoire in each mouse model were elicited as evaluated by measuring surface CD69 and CD25, intracellular IFN-γ, tetramer staining and cytolysis of melanoma cells. Furthermore, the aAPCs efficiently inhibited subcutaneous tumor growth and markedly delayed tumor progression in tumor-bearing mice. These data suggest that bead-based aAPCs represent a potential strategy for the active immunotherapy of cancers or persistent infections.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328744     DOI: 10.1016/j.imlet.2013.01.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

Review 1.  Biomimetic and synthetic interfaces to tune immune responses.

Authors:  Anusha Garapaty; Julie A Champion
Journal:  Biointerphases       Date:  2015-09-15       Impact factor: 2.456

Review 2.  Nanoscale artificial antigen presenting cells for cancer immunotherapy.

Authors:  Kelly R Rhodes; Jordan J Green
Journal:  Mol Immunol       Date:  2018-03-07       Impact factor: 4.407

3.  CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.

Authors:  Heiko Bruns; Catherine Bessell; Juan Carlos Varela; Carl Haupt; Jerry Fang; Shirin Pasemann; Andreas Mackensen; Mathias Oelke; Jonathan P Schneck; Christian Schütz
Journal:  Clin Cancer Res       Date:  2015-01-15       Impact factor: 12.531

4.  Cell-sized lipid vesicles for cell-cell synaptic therapies.

Authors:  D Vallejo; S H Lee; D Lee; C Zhang; C Rapier; S D Chessler; A P Lee
Journal:  Technology (Singap World Sci)       Date:  2018-01-24

Review 5.  Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.

Authors:  Ariel Isser; Natalie K Livingston; Jonathan P Schneck
Journal:  Biomaterials       Date:  2020-12-05       Impact factor: 15.304

Review 6.  Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.

Authors:  Chao Wang; Wujin Sun; Yanqi Ye; Hunter N Bomba; Zhen Gu
Journal:  Theranostics       Date:  2017-08-17       Impact factor: 11.556

7.  Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation.

Authors:  Alyssa K Kosmides; Kevin Necochea; John W Hickey; Jonathan P Schneck
Journal:  Nano Lett       Date:  2018-02-28       Impact factor: 11.189

8.  Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.

Authors:  A K Kosmides; R A Meyer; J W Hickey; K Aje; K N Cheung; J J Green; J P Schneck
Journal:  Biomaterials       Date:  2016-12-02       Impact factor: 12.479

Review 9.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Authors:  Karlo Perica; Alyssa K Kosmides; Jonathan P Schneck
Journal:  Biochim Biophys Acta       Date:  2014-09-06

Review 10.  Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.

Authors:  Loek J Eggermont; Leonie E Paulis; Jurjen Tel; Carl G Figdor
Journal:  Trends Biotechnol       Date:  2014-07-03       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.